A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide

NCT00234520 · clinicaltrials.gov ↗
COMPLETED
Status
225
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Ipsen